Differential changes in platelet VEGF, Tsp, CXCL12, and CXCL4 in patients with metastatic cancer

Clinical and Experimental Metastasis

Volumn 27, Issue 3, 2010, Pages 141-149

  Wiesner, Tina ^a   Bugl, Stefanie ^a   Mayer, Frank ^a   Hartmann, Jörg T ^a   Kopp, Hans Georg ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

CXCL12; CXCL4; Metastasis; Platelets; Thrombospondin; VEGF A

Indexed keywords

CXCL14 CHEMOKINE; STROMAL CELL DERIVED FACTOR 1; THROMBOSPONDIN 1; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPOTHESIS; MALE; MASS SPECTROMETRY; MEGAKARYOPOIESIS; METASTASIS; PHENOTYPE; THROMBOCYTE; THROMBOCYTE COUNT; XENOTRANSPLANTATION;

ANIMALS; BLOOD PLATELETS; CASE-CONTROL STUDIES; CHEMOKINE CXCL12; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MASS SPECTROMETRY; MEGAKARYOCYTES; MICE; NEOPLASM METASTASIS; NEOPLASM STAGING; PLATELET COUNT; PLATELET FACTOR 4; THROMBOSPONDIN 1; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 77950858461     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-010-9311-6     Document Type: Article

References (48)

1. Billroth T(1878) Lectures on surgical pathology and therapeutics: a handbook for students and practitioners. New Sydenham Society. 355. London. [Ref Type: Serial (Book, Monograph)]
2. L Borsig R Wong J Feramisco, et al. 2001 Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis Proc Natl Acad Sci USA 98 3352 3357 10.1073/pnas.061615598 1:CAS:528:DC%2BD3MXit1altrc%3D 11248082 (Pubitemid 32220849)
3. GJ Gasic TB Gasic CC Stewart 1968 Antimetastatic effects associated with platelet reduction Proc Natl Acad Sci USA 61 46 52 10.1073/pnas.61.1.46 1:CAS:528:DyaF1MXhtVartg%3D%3D 5246932
4. DK Jin K Shido HG Kopp, et al. 2006 Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4 + hemangiocytes Nat Med 12 557 567 10.1038/nm1400 1:CAS:528:DC%2BD28Xkt1Kju7o%3D 16648859
5. B Nieswandt M Hafner B Echtenacher, et al. 1999 Lysis of tumor cells by natural killer cells in mice is impeded by platelets Cancer Res 59 1295 1300 1:CAS:528:DyaK1MXhvFehtbo%3D 10096562 (Pubitemid 29136261)
6. J Folkman Y Shing 1992 Angiogenesis J Biol Chem 267 10931 10934 1:CAS:528:DyaK38XksVSmu7s%3D 1375931
7. N Ferrara HP Gerber J LeCouter 2003 The biology of VEGF and its receptors Nat Med 9 669 676 10.1038/nm0603-669 1:CAS:528:DC%2BD3sXktFOnur4%3D 12778165 (Pubitemid 36749215)
8. LY Dirix PB Vermeulen G Hubens, et al. 1996 Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancer Ann Oncol 7 843 848 1:STN:280:DyaK2s%2FotVyltg%3D%3D 8922199 (Pubitemid 26345876)
9. ML George SA Eccles MG Tutton, et al. 2000 Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging? Clin Cancer Res 6 3147 3152 1:CAS:528:DC%2BD3cXmsVOmtr0%3D 10955796
10. ML George MG Tutton F Janssen, et al. 2001 VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression Neoplasia 3 420 427 10.1038/sj.neo.7900186 1:CAS:528:DC%2BD3MXot1Sluro%3D 11687953 (Pubitemid 32988812)
11. W Jelkmann 2001 Pitfalls in the measurement of circulating vascular endothelial growth factor Clin Chem 47 617 623 1:CAS:528:DC%2BD3MXis1Kjurw%3D 11274009 (Pubitemid 32275802)
12. R Mohle D Green MA Moore, et al. 1997 Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets Proc Natl Acad Sci USA 94 663 668 10.1073/pnas.94.2.663 1:CAS:528:DyaK2sXnvVejsQ%3D%3D 9012841 (Pubitemid 27053690)
13. G Pintucci S Froum J Pinnell, et al. 2002 Trophic effects of platelets on cultured endothelial cells are mediated by platelet-associated fibroblast growth factor-2 (FGF-2) and vascular endothelial growth factor (VEGF) Thromb Haemost 88 834 842 12428103 (Pubitemid 35345345)
14. C Fernandez-Patron MA Martinez-Cuesta E Salas, et al. 1999 Differential regulation of platelet aggregation by matrix metalloproteinases-9 and -2 Thromb Haemost 82 1730 1735 1:CAS:528:DyaK1MXotVeht7Y%3D 10613662
15. HG Kopp AT Hooper MJ Broekman, et al. 2006 Thrombospondins deployed by thrombopoietic cells determine angiogenic switch and extent of revascularization J Clin Invest 116 3277 3291 10.1172/JCI29314 1:CAS:528:DC%2BD28XhtlWgsbnL 17143334 (Pubitemid 44878642)
16. TE Maione GS Gray J Petro, et al. 1990 Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides Science 247 77 79 10.1126/science.1688470 1:CAS:528:DyaK3cXhslKgs7g%3D 1688470 (Pubitemid 20059941)
17. A Brill H Elinav D Varon 2004 Differential role of platelet granular mediators in angiogenesis Cardiovasc Res 63 226 235 10.1016/j.cardiores.2004.04. 012 1:CAS:528:DC%2BD2cXlsFymuro%3D 15249180 (Pubitemid 38900837)
18. FJ Gonzalez A Rueda I Sevilla, et al. 2004 Shift in the balance between circulating thrombospondin-1 and vascular endothelial growth factor in cancer patients: relationship to platelet alpha-granule content and primary activation Int J Biol Markers 19 221 228 1:CAS:528:DC%2BD2cXhtVyku73M 15503824 (Pubitemid 39406244)
19. JS Palumbo KE Talmage JV Massari, et al. 2005 Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells Blood 105 178 185 10.1182/blood-2004-06-2272 1:CAS:528:DC%2BD2MXis1Gruw%3D%3D 15367435 (Pubitemid 40053080)
20. JS Palumbo KE Talmage JV Massari, et al. 2007 Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms Blood 110 133 141 10.1182/blood-2007-01-065995 1:CAS:528: DC%2BD2sXnsVaisL8%3D 17371949 (Pubitemid 47026828)
21. HG Kopp T Placke HR Salih 2009 Platelet-derived transforming growth factor-{beta} down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity Cancer Res 69 7775 7778 10.1158/0008-5472.CAN-09-2123 1:CAS:528:DC%2BD1MXht1Skt7nP 19738039
22. D Cervi TT Yip N Bhattacharya, et al. 2008 Platelet-associated PF-4 as a biomarker of early tumor growth Blood 111 1201 1207 10.1182/blood-2007-04-084798 1:CAS:528:DC%2BD1cXhvFejtrc%3D 17914028 (Pubitemid 351213401)
23. HJ Kim CH Chung CO Moon, et al. 1990 Determinants of magnitude of pseudohyperkalemia in thrombocytosis Korean J Intern Med 5 97 100 1:STN:280:DyaK3M3nsVarsg%3D%3D 2098099
24. E Hormbrey C Han A Roberts, et al. 2003 The relationship of human wound vascular endothelial growth factor (VEGF) after breast cancer surgery to circulating VEGF and angiogenesis Clin Cancer Res 9 4332 4339 1:CAS:528:DC%2BD3sXotVShsLs%3D 14555503 (Pubitemid 37248388)
25. G Gastl M Plante CL Finstad, et al. 1993 High IL-6 levels in ascitic fluid correlate with reactive thrombocytosis in patients with epithelial ovarian cancer Br J Haematol 83 433 441 10.1111/j.1365-2141.1993.tb04668.x 1:STN:280:DyaK3s3kvFykug%3D%3D 8485049 (Pubitemid 23080014)
26. HM Verheul HM Pinedo 2003 The importance of platelet counts and their contents in cancer Clin Cancer Res 9 3219 3221 1:CAS:528:DC%2BD3sXotFCks7Y%3D 12960106
27. E Hormbrey P Gillespie K Turner, et al. 2002 A critical review of vascular endothelial growth factor (VEGF) analysis in peripheral blood: is the current literature meaningful? Clin Exp Metastasis 19 651 663 10.1023/A:1021379811308 1:CAS:528:DC%2BD38Xpt1Kqur4%3D 12553370 (Pubitemid 36092260)
28. J Kappelmayer B Nagy Jr K Miszti-Blasius, et al. 2004 The emerging value of P-selectin as a disease marker Clin Chem Lab Med 42 475 486 10.1515/CCLM.2004.082 1:CAS:528:DC%2BD2cXkslCnsb8%3D 15202782 (Pubitemid 38779747)
29. RK Jain 2002 Tumor angiogenesis and accessibility: role of vascular endothelial growth factor Semin Oncol 29 3 9 1:CAS:528:DC%2BD3sXlvFSqsA%3D%3D 12516032
30. RK Jain 2009 A new target for tumor therapy N Engl J Med 360 2669 2671 10.1056/NEJMcibr0902054 1:CAS:528:DC%2BD1MXntlKmurk%3D 19535806
31. W Wynendaele R Derua MF Hoylaerts, et al. 1999 Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers: a key to study an angiogenic marker in vivo? Ann Oncol 10 965 971 10.1023/A:1008377921886 1:STN:280:DyaK1MvjvVGktA%3D%3D 10509160 (Pubitemid 29424578)
32. NL Baenziger GN Brodie PW Majerus 1971 A thrombin-sensitive protein of human platelet membranes Proc Natl Acad Sci USA 68 240 243 10.1073/pnas.68.1.240 1:CAS:528:DyaE3MXntlyluw%3D%3D 5276296
33. DJ Good PJ Polverini F Rastinejad, et al. 1990 A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin Proc Natl Acad Sci USA 87 6624 6628 10.1073/pnas.87.17.6624 1:CAS:528:DyaK3cXls12lt70%3D 1697685 (Pubitemid 20351533)
34. JC Adams J Lawler 2004 The thrombospondins Int J Biochem Cell Biol 36 961 968 10.1016/j.biocel.2004.01.004 1:CAS:528:DC%2BD2cXjt1antr0%3D 15094109 (Pubitemid 38528716)
35. P Clezardin L Frappart M Clerget, et al. 1993 Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast Cancer Res 53 1421 1430 1:CAS:528: DyaK3sXisFagtbw%3D 7680285 (Pubitemid 23097127)
36. JA Coppinger G Cagney S Toomey, et al. 2004 Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions Blood 103 2096 2104 10.1182/blood-2003-08-2804 1:CAS:528:DC%2BD2cXitlequr8%3D 14630798 (Pubitemid 38326225)
37. T Nagasawa T Nakajima K Tachibana, et al. 1996 Molecular cloning and characterization of a murine pre-B-cell growth-stimulating factor/stromal cell-derived factor 1 receptor, a murine homolog of the human immunodeficiency virus 1 entry coreceptor fusin Proc Natl Acad Sci USA 93 14726 14729 10.1073/pnas.93.25.14726 1:CAS:528:DyaK28XnsVOjsLY%3D 8962122 (Pubitemid 26419036)
38. T Nagasawa 2000 A chemokine, SDF-1/PBSF, and its receptor, CXC chemokine receptor 4, as mediators of hematopoiesis Int J Hematol 72 408 411 1:CAS:528:DC%2BD3MXntVSjsg%3D%3D 11197205
39. M Grunewald I Avraham Y Dor, et al. 2006 VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells Cell 124 175 189 10.1016/j.cell.2005.10.036 1:CAS:528:DC%2BD28XntVGkug%3D%3D 16413490 (Pubitemid 43069318)
40. DE Wright EP Bowman AJ Wagers, et al. 2002 Hematopoietic stem cells are uniquely selective in their migratory response to chemokines J Exp Med 195 1145 1154 10.1084/jem.20011284 1:CAS:528:DC%2BD38Xjs1Wnu78%3D 11994419 (Pubitemid 34517140)
41. JA Stuckey R St Charles BF Edwards 1992 A model of the platelet factor 4 complex with heparin Proteins 14 277 287 10.1002/prot.340140213 1:CAS:528:DyaK38Xmt1ylsbg%3D 1409574
42. RJ Sharpe HR Byers CF Scott, et al. 1990 Growth inhibition of murine melanoma and human colon carcinoma by recombinant human platelet factor 4 J Natl Cancer Inst 82 848 853 10.1093/jnci/82.10.848 1:CAS:528:DyaK3cXkslSrsb4%3D 1692094
43. RL Nachman S Rafii 2008 Platelets, petechiae, and preservation of the vascular wall N Engl J Med 359 1261 1270 10.1056/NEJMra0800887 1:CAS:528:DC%2BD1cXhtFGisrzP 18799560
44. J Kisucka CE Butterfield DG Duda, et al. 2006 Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage Proc Natl Acad Sci USA 103 855 860 10.1073/pnas.0510412103 1:CAS:528:DC%2BD28XhsVKgtrw%3D 16418262 (Pubitemid 43212187)
45. L Borsig 2008 The role of platelet activation in tumor metastasis Expert Rev Anticancer Ther 8 1247 1255 10.1586/14737140.8.8.1247 1:CAS:528: DC%2BD1cXhtVWgu7zE 18699763
46. RK Jain 2005 Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy Science 307 58 62 10.1126/science.1104819 1:CAS:528:DC%2BD2MXnvFar 15637262 (Pubitemid 40093472)
47. B Dome MJ Hendrix S Paku, et al. 2007 Alternative vascularization mechanisms in cancer: pathology and therapeutic implications Am J Pathol 170 1 15 10.2353/ajpath.2007.060302 1:CAS:528:DC%2BD2sXhsV2gtbw%3D 17200177 (Pubitemid 47339184)
48. N Kieffer J Guichard JP Farcet, et al. 1987 Biosynthesis of major platelet proteins in human blood platelets Eur J Biochem 164 189 195 10.1111/j.1432-1033.1987.tb11010.x 1:CAS:528:DyaL2sXhsFersro%3D 3830180 (Pubitemid 17053683)